BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$615M |
| 2 |
State Street SPDR S&P Retail ETF
XRT
|
+$231M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$229M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$186M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$620M |
| 3 |
Tesla
TSLA
|
+$594M |
| 4 |
Apple
AAPL
|
+$541M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.24% |
| 2 | Financials | 6.85% |
| 3 | Healthcare | 5.31% |
| 4 | Consumer Discretionary | 4.97% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
PUT
Altria Group
MO
$109B
| $54.6K | ﹤0.01% |
12
| – | – |
|
|
INFI
3352
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $54.5K | ﹤0.01% |
15,947
+12,576
| +373% | +$38.8K |
|
3353
Bassett Furniture
BSET
$171M
| $54.3K | ﹤0.01% |
2,997
+1,785
| +147% | +$39.2K |
|
|
CSLT
3354
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $54.2K | ﹤0.01% |
34,530
+21,693
| +169% | +$42.5K |
|
|
SAND
3355
DELISTED
Sandstorm Gold
SAND
| $54.1K | ﹤0.01% |
9,386
+299
| +3% | +$2.06K |
|
|
TECX
3356
Tectonic Therapeutic
TECX
$690M
| $53.9K | ﹤0.01% |
805
+426
| +112% | +$35K |
|
|
LUNA
3357
DELISTED
Luna Innovations Incorporated
LUNA
| $53.9K | ﹤0.01% |
5,673
+4,373
| +336% | +$47.2K |
|
3358
Mayville Engineering Co
MEC
$601M
| $53.7K | ﹤0.01% |
2,856
+1,691
| +145% | +$29K |
|
|
LITS
3359
Lite Strategy Inc
LITS
$30.6M
| $53.6K | ﹤0.01% |
972
+781
| +409% | +$43K |
|
|
ATNX
3360
DELISTED
Athenex, Inc. Common Stock
ATNX
| $53.6K | ﹤0.01% |
890
+723
| +433% | +$52.6K |
|
3361
Capital Bancorp
CBNK
$614M
| $53.6K | ﹤0.01% |
2,226
+890
| +67% | +$19.9K |
|
3362
eGain
EGAN
$201M
| $53.2K | ﹤0.01% |
5,212
+4,285
| +462% | +$48.4K |
|
3363
Coastal Financial
CCB
$774M
| $53.1K | ﹤0.01% |
1,667
+1,363
| +448% | +$40.6K |
|
|
ESTE
3364
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $52.9K | ﹤0.01% |
5,746
+2,124
| +59% | +$19.5K |
|
3365
Fidelity D&D Bancorp
FDBC
$325M
| $52.9K | ﹤0.01% |
1,048
+547
| +109% | +$28.7K |
|
|
GORV
3366
DELISTED
Lazydays
GORV
| $52.8K | ﹤0.01% |
83
+51
| +159% | +$34.2K |
|
3367
Harvard Bioscience
HBIO
$30M
| $52.7K | ﹤0.01% |
755
+627
| +490% | +$49.9K |
|
|
PAMT
3368
PAMT Corp
PAMT
$282M
| $52.7K | ﹤0.01% |
2,342
+570
| +32% | +$9.79K |
|
3369
Rafael Holdings
RFL
$108M
| $52.3K | ﹤0.01% |
1,726
+1,375
| +392% | +$63.1K |
|
|
APLT
3370
DELISTED
Applied Therapeutics
APLT
| $52K | ﹤0.01% |
3,135
+2,367
| +308% | +$40.9K |
|
|
TEF
3371
DELISTED
Telefonica
TEF
| $51.9K | ﹤0.01% |
11,817
+989
| +9% | +$4.4K |
|
|
IHC
3372
DELISTED
Independence Holding Company
IHC
| $51.8K | ﹤0.01% |
1,044
+403
| +63% | +$18.5K |
|
|
CBAY
3373
DELISTED
Cymabay Therapeutics
CBAY
| $50.7K | ﹤0.01% |
13,884
+6,938
| +100% | +$27.3K |
|
|
MRLN
3374
DELISTED
Marlin Business Services Corp
MRLN
| $49.9K | ﹤0.01% |
2,244
+396
| +21% | +$8.88K |
|
3375
TherapeuticsMD
TXMD
$24.2M
| $49.5K | ﹤0.01% |
1,336
+1,073
| +408% | +$47.6K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2021 Portfolio in Review
As of Q3 2021, BNP Paribas Financial Markets held 4,161 positions worth $70.6B, down 6.6% from $75.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.5B in Q3 2021, closing 150 positions and reducing 1,194 holdings. Its most notable exit was GE Aerospace, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares 10+ Year Investment Grade Corporate Bond ETF worth $5.86M.
- BNP Paribas Financial Markets's largest Q3 2021 buy was iShares 10+ Year Investment Grade Corporate Bond ETF: 84,600 shares worth $5.86M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2021, an estimated $615M increase.
- BNP Paribas Financial Markets's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.24B.
- BNP Paribas Financial Markets fully exited GE Aerospace in Q3 2021, selling an estimated $147M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $70.6B portfolio in Q3 2021.
- BNP Paribas Financial Markets opened 102 new positions and closed 150 in Q3 2021.
- BNP Paribas Financial Markets's portfolio value fell 6.6% quarter-over-quarter to $70.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.